Results 121 to 130 of about 1,948,245 (257)

Identification and characterisation of endogenous inducible promoters in Mycobacterium tuberculosis [PDF]

, 2010
PhDMycobacterium tuberculosis is one of the world’s most devastating pathogens. Despite completion of the genome sequence in 1998, research progress has been hampered by a lack of genetic tools and the difficulty of working with the organism. Existing
Schuessler, Dorothée Laura
core   +1 more source

Animal models for tuberculosis

, 2019
Outline: -- History of tuberculosis -- Treatment -- Animals and TB -- Animal models -- Vaccination -- Mouse models -- Challenge experiments ...
Natalie Parlane (14475594)
core  

Barriers and Facilitators to the Implementation of the Weekend‐70 Cervical Cancer Screening Programme in Mali: A Multiple Case Study

The International Journal of Health Planning and Management, EarlyView.
ABSTRACT Introduction Cervical cancer (CC) represents a significant public health issue in low‐ and middle‐income countries. In Mali, the Weekend‐70 cervical cancer screening programme, initially implemented in Bamako (the capital), is gradually being rolled out in other regions.
Aminata Adama Ndour, Sabina Abou Malham, David‐Martin Milot, Geneviève Baron, Ibrahima Téguété, Mahamane Maiga, Kadidia Bokar   +6 more
wiley   +1 more source

Development and Challenges in Animal Tuberculosis Vaccination. [PDF]

Pathogens, 2020
Balseiro A, Thomas J, Gortázar C, Risalde MA.   +3 more
europepmc   +1 more source

Tuberculosis : general information [Dari]

Tuberculosis : general information [Dari]CS227840_ATB-elimination-august-2021-pdf-dari ...

core  

Human immunodeficiency virus increases the risk of tuberculosis due to recent re-infection in individuals with latent infection. [PDF]

, 2010
BACKGROUND: Human immunodeficiency virus associated tuberculosis (TB) disease can follow reactivation of latent Mycobacterium tuberculosis infection or recent (re-)infection with M. tuberculosis. If contemporary TB cases share identical M.
Fine, P.E.M., Glynn, J.R., Mallard, K., Sichali, L., Crampin, A.C., Mallard, K, French, N, Houben, RMGJ, Malema, S, Glynn, JR, Sichali, L, Houben, R.M.G.J, Malema, S., Crampin, AC, Fine, PEM, French, N.   +15 more
core  

Evaluating the diagnostic value of PLR and related hematologic parameters combined with CA‐125 for endometriomas

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective Endometriosis is a chronic inflammatory disease, with inflammation relating to pathogenesis and staging. We compared inflammatory indices and clinical characteristics between patients with ovarian endometriomas and those with benign ovarian tumors to evaluate their diagnostic value and identify affordable blood markers for diagnosis ...
Pingping Su, Yanni Huang, Fenhong Kang, Lili Zhang, Lirui Yu, Hongli Liu   +5 more
wiley   +1 more source

Quantification of the Animal Tuberculosis Multi-Host Community Offers Insights for Control. [PDF]

Pathogens, 2020
Santos N, Richomme C, Nunes T, Vicente J, Alves PC, de la Fuente J, Correia-Neves M, Boschiroli ML, Delahay R, Gortázar C.   +9 more
europepmc   +1 more source

Organ‐Resolved Host Proteomic and Post‐Translational Modification Landscapes in a Mouse Model of Talaromyces marneffei Infection

iMetaMed, EarlyView.
We presented an organ‐resolved, multiple PTM remodeling atlas of systemic T. marneffei infection, integrating quantitative proteome, phosphoproteome, ubiquitinome, acetylome, and lactylome data across the liver, lung, and spleen. The atlas delineated organ‐specific PTM signatures and a functional convergence of divergent modification types on immune ...
Wudi Wei, Shiyi Lai, Xiaotao He, Xiaoting Wei, Xiaoting Xie, Weihong Huang, Baili Zhan, Meng Zhang, Zongxiang Yuan, Rongfeng Chen, Jingzhen Lai, Yuyuan Huang, Kang Li, Sanqi An, Li Ye, Hao Liang, Junjun Jiang   +16 more
wiley   +1 more source

Tofacitinib Regulates β‐Catenin Nuclear Translocation to Inhibit FLS Migration and Alleviate Clinical Symptoms of RA

iNew Medicine, EarlyView.
ABSTRACT Objective Tofacitinib is a Janus kinase (JAK) inhibitor approved for the treatment of moderate‐to‐severe rheumatoid arthritis (RA). However, its synovium‐related molecular mechanisms, particularly its regulatory effect on fibroblast‐like synoviocyte (FLS) migration, remain incompletely understood.
Shuqi Fang, Tianjing Zhang, Ling Hu, Ruijin Liu, Leyi Jia, Menglin Bai, Jiale Dong, Yuchen Zhao, Han Wang, Lei Zhang, Tao Li, Youcai Deng, Xianzheng Zhang, Lingling Zhang   +13 more
wiley   +1 more source